Since the mid-1980s, six times as many men under 55 now are receiving prostate cancer diagnoses, and the younger patients face considerably higher mortality rates. With the stakes even greater, the debate continues on whether too much screening is being… Read More
LOS ANGELES — African-Americans’ participation in colorectal cancer screening is low, and the use of colonoscopy infrequent despite similar access to care in a specific Veterans Affairs healthcare system, according to a new study. The report, which appeared in GIE:… Read More
SAN FRANCISCO — How long does it take for the benefit of screening flexible sigmoidoscopy to accrue for colorectal cancer? A new study suggests it is most appropriate for older adults with a life expectancy greater than about 10 years.… Read More
ANN ARBOR, MI — Rather than gambling on their health, veterans at the Philadelphia VA Healthcare System entered a lottery by agreeing to undergo colon cancer screening. Told they had a 1-in-10 chance of winning $50, patients were more likely… Read More
COLUMBIA, MO – Often spurred by advertising touting the benefits of testosterone supplementation for “low T,” veterans treated by the VA increasingly are requesting the replacement therapy.
CHAPEL HILL, NC – Physicians commonly recommend statins for veterans with high triglyceride levels.
JOHNSON CITY, TN – Consistent with past European studies, new research from the Mountain Home VAMC suggests that transgender (TG) veterans have no higher rates of breast cancer than others. The study, published recently in the journal Breast Cancer Research… Read More
SAN DIEGO – African-American women present with more aggressive breast tumors and at later stages than white women. Many factors have been proposed to explain these findings, including socioeconomic status, cultural beliefs and access to medical care. A new military… Read More
NASHVILLE – Many more breast cancer patients now opt for mastectomy, including removal of both breasts, instead of choosing breast conservation surgery (BCS), even with early-stage disease confined to one breast, according to a new study. The rates of increase… Read More
INDIANAPOLIS – The approved use of Cyramza (ramucirumab) has been expanded to treat patients with metastatic non-small cell lung cancer (NSCLC). Cyramza, marketed by Eli Lilly, blocks the blood supply that fuels tumor growth. The drug is approved for patients… Read More
PRINCETON, NJ – Accelerated approval has been granted by the Food and Drug Administration to Opdivo (nivolumab), a new treatment for patients with unresectable or metastatic melanoma who no longer respond to other drugs. Opdivo, marketed by Bristol-Myers Squibb, works… Read More
PLAINSBORO, NJ – The Food and Drug Administration has approved a new treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. Saxenda (liraglutide [rDNA origin] injection) is approved for use in adults with a… Read More
Alliance Research Not Limited by Private-Sector Restraints By Annette M. Boyle BETHESDA, MD – In celebration of its second anniversary, the John P. Murtha Cancer Center at the Walter Reed National Military Medical Center, announced plans to substantially expand its… Read More
HOUSTON – Decades later, exposure to Agent Orange puts Vietnam War veterans at high risk for certain types of skin cancer. That’s according to a report published earlier this year in Find Your Surgeon Plastic and Reconstructive Surgery, the official… Read More
NASHVILLE – Military personnel deployed abroad in climates such as Afghanistan and Iraq have increased risk factors for skin cancer, according to a new study. The increased risk is especially present when servicemembers serve in tropical and sunny climates, according… Read More
By Brenda L. Mooney PITTSBURGH – Will hepatitis C become a rare disease over the next two decades or so? The answer is yes, according to a computer simulation conducted by the University of Pittsburgh Graduate School of Public Health… Read More
FORT LEWIS-MCCHORD, WA – The DoD’s leadership in cancer research started accidentally, but funding from Congress has ensured that both the Army and VA have remained on the front lines in the war on cancer during the past 50 years.